Results 131 to 140 of about 33,569 (238)

Association of BRCA Mutation Status with Clinical Outcomes in High-Grade Serous Ovarian Cancer. [PDF]

Healthcare (Basel)
Petrusan AM, Feier CVI, Muntean C, Gaborean V, Petrusan AS, Nicoara D, Puscas EM, Puia IPT, Pasca A, Achimaș-Cadariu P.   +9 more
europepmc   +1 more source

Low‐Grade Serous Carcinoma in Association With Endosalpingiosis in a Cervical Lymph Node: A Case Report and Literature Review

Diagnostic Cytopathology, Volume 54, Issue 12, Page E319-E323, December 2026.
ABSTRACT Endosalpingiosis is a benign Müllerian inclusion that rarely involves supradiaphragmatic lymph nodes. Malignant transformation in the setting of nodal endosalpingiosis is exceptional. We report a case of low‐grade serous carcinoma arising in a cervical lymph node in the setting of endosalpingiosis in a 41‐year‐old woman presenting with Horner ...
Nyein Nyein Htun, Nour Sneige
wiley   +1 more source

Cost-effectiveness of fuzuloparib, with or without apatinib, for BRCA mutation HER2-negative metastatic breast cancer in China. [PDF]

Front Pharmacol
Fu Y, Li Z, Xia Q, Chen X, Xiang Z.
europepmc   +1 more source

Epigenetic Markers of Cell Division and Ageing in Relation to Breast Cancer Survival

International Journal of Cancer, Volume 159, Issue 10, Page 2452-2462, 15 November 2026.
ABSTRACT Breast cancer remains a major challenge to public health. Biomarkers may be useful to improve prediction of breast cancer survival. Several epigenetic markers of cell division and ageing based on DNA methylation have been proposed. In this study, we measured these epigenetic markers in breast tumours and assessed their prognostic value.
Luca Li, Elaheh Zarean, Danmeng Lily Li, Yiyue Zhu, Shuai Li, Enes Makalic, Catriona McLean, Graham G. Giles, Roger L. Milne, Melissa C. Southey, Pierre‐Antoine Dugué   +10 more
wiley   +1 more source

Evaluating high-risk breast cancer surveillance outcomes in BRCA mutation carriers. [PDF]

Breast Cancer
Chang YK, Luk WP, Fung LH, Kwong A.
europepmc   +1 more source

High Level of Component C1q Binding Protein (C1QBP) is Associated With Poor Prognosis and Dysfunction of Mast Cells in Lung Adenocarcinoma

Cancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Component C1q binding protein (C1QBP) is known as an important regulator of mitochondrial plasticity and is involved in antitumor immune response in cancers. Nevertheless, its role in lung adenocarcinoma (LUAD) still remains largely unknown.
Wei Li, Guangnan Huang, Lizhong Zeng, Wenhui Dang, Ting Jiao, Yonghong Zhang, Mengying Zhang, Shuru Zhou, Liping Chen, Shuanying Yang   +9 more
wiley   +1 more source

Prediction of germline BRCA mutation using clinicopathologic, MRI semantic, and radiomics features in high-risk breast cancer patients: a multicenter study. [PDF]

Front Radiol
Cho YS, Oh E, Han YJ, Cho KR, Park KH, Song SE.   +5 more
europepmc   +1 more source

Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients? [PDF]

J Natl Cancer Inst, 2023
Lee MK, Robson ME.
europepmc   +1 more source

Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11). [PDF]

Breast Cancer Res
Shin SH, Ahn SG, Ryu JM, Lee SB, Park HS, Lee ES, Lee J, Kang B, Kim S, Kim EY, Kang YJ, Min SY, Lee M, Kim SK, Kim HK, Cha CD, and the Korea Robot endoscopy Minimal Access BreastSurgery Study Group.   +16 more
europepmc   +1 more source

Decision regret following rapid genetic testing at the time of breast cancer diagnosis

Cancer, Volume 132, Issue 21, 1 November 2026.
ABSTRACT Introduction Genetic testing is increasingly being offered at the time of breast cancer diagnosis to help women guide their treatment decisions. The objective of the current study was to measure decision regret 1 year after genetic testing and to evaluate the factors associated with regret.
Ling‐Fang Hsu, Andrea Eisen, Aletta Poll, David W. Lim, Frances C. Wright, Renee Hanrahan, Alana Hosein, Tuya Pal, Steven Narod, Kelly Metcalfe   +9 more
wiley   +1 more source